以非肿块型生长为倾向的乳腺癌影像检查:浸润性小叶癌与导管原位癌——影像能否全部捕捉?
本文综述浸润性小叶癌(ILC)与导管原位癌(DCIS)的分子机制和组织病理学模式,阐述这些机制如何转化为不同的临床与影像表现,并讨论其对分期检查和患者管理流程的影响,指出两者影像评估与优化治疗策略相互依赖。
要点
- ILC与DCIS均以非肿块型生长为倾向,临床与影像表现常较隐匿。
- 两者的分子机制和组织病理学模式决定其生物学行为与影像表现。
- 影像评估的充分性与优化治疗策略在乳腺诊疗中相互依赖。
核心结论
- ILC与DCIS的分子机制和组织病理学模式可解释其不同的临床与影像表现,并影响分期检查与患者管理流程。
研究设计与样本
- 本文为综述,检索范围与纳入文献原文未报告。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE. Invasive lobular carcinoma (ILC) and ductal carcinoma in situ (DCIS) are distinct histopathologic entities with several commonalities: both have subtle clinical and imaging presentation, have been linked with controversy regarding optimal imaging techniques and management, and exemplify the codependence of adequate imaging evaluation and optimal treatment strategies in breast care. CONCLUSION. We review molecular mechanisms and histopathologic patterns that define the biologic behavior of both ILC and DCIS and discuss how these mechanisms translate into distinct clinical and imaging presentations that affect the staging workup and patient management algorithm.
引用
- Weaver O, Yang W. Imaging of Breast Cancers With Predilection for Nonmass Pattern of Growth: Invasive Lobular Carcinoma and DCIS-Does Imaging Capture It All? AJR Am J Roentgenol. 2020. PMID: 33021831. doi:10.2214/AJR.19.22027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。